Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa” or the "Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced its financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback